Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Why Do We Adjust Index Divisor covers the core reasons behind adjustments, including corporate actions and market events, and how they affect benchmarks.
20,620 articlesTeva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
A leading LNG stock jumped 32% this stock year, investor took profits, and a massive exit followed. Here’s how to und...
Life360 delivered a strong quarter, but user growth hiccups and a lofty valuation rattled investors. This piece break...
A mid-size fund reduced its TriMas stake by about $5 million after a strong run, but didn’t exit the position entirel...
Investors spotted a notable move in the mining space as Coeur Mining stock popped after an earnings beat. This piece ...
Artificial intelligence is reshaping markets, but one big risk many investors fear may be overblown. This article exp...
A Nobel Prize–winning economist says U.S. democracy hinges on two policy shifts tied to AI and inequality. He outline...
The federal debt breached $39 trillion this week as lawmakers debated a constitutional fix that failed to pass. The p...
With policy tailwinds and growing demand, the solar sector remains a core focus for 2026. Here are the best solar sto...
CoreWeave has rallied this year as AI infrastructure demand heats up. This article breaks down why the stock around t...
As 2026 reshapes real estate marketing, a new ranking spotlights the 10 best real estate marketing firms. Agents and ...
Private credit making investors nervous highlights how market risk, defaults, and liquidity affect BDCs. Yet Main Str...